PRESS RELEASE published on 04/29/2026 at 06:59, 2 months 8 days ago ALSO Q1 2026: Net Profit +69%, EBITDA 89 million euros (+46%), ROCE 11.2% (+0.8 percentage points) ALSO Holding AG reports impressive financial results for Q1 2026 with a significant increase in net profit, EBITDA, and ROCE. The company confirms positive outlook and growth potential for the future Financial Results EBITDA ALSO Holding AG Growth Potential Q1 2026
PRESS RELEASE published on 04/29/2026 at 06:58, 2 months 8 days ago DWS With Solid Start into the Year DWS Group GmbH & Co. KGaA reports solid financial results for Q1 2026, with improvements in revenues, costs, profit, and assets under management. Quarterly net flows and key metrics show positive growth Financial Results Assets Under Management DWS Group Q1 2026 Net Flows
PRESS RELEASE published on 04/29/2026 at 06:49, 2 months 8 days ago Nagarro releases audited financial statements and annual report for FY 2025, reaffirms the preliminary numbers Nagarro SE releases audited financial statements for FY 2025, with revenue of €999 million (+2.8%) and reaffirms preliminary numbers. They propose a dividend of €1.00 per share Financial Statements Revenue Dividend Nagarro SE FY 2025
PRESS RELEASE published on 04/29/2026 at 06:30, 2 months 8 days ago Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing Siegfried DINAMIQS, a Siegfried company, receives Swissmedic license for viral vector cGMP production, marking a milestone in expanding Siegfried's advanced therapies capabilities Advanced Therapies CGMP Production Swissmedic License Siegfried DINAMIQS Viral Vector
PRESS RELEASE published on 04/29/2026 at 05:10, 2 months 8 days ago Silver Spruce Resources Inc. Announces Adjournment of Annual General and Special Meeting of Shareholders Silver Spruce Resources Inc. adjourns 2026 annual general meeting to May 5, 2026. Shareholders urged to vote by May 4. Details in Meeting Information Circular Annual General Meeting Shareholders Silver Spruce Resources Inc. Voting Adjournment
PRESS RELEASE published on 04/29/2026 at 04:50, 2 months 8 days ago Alaska Energy Metals Extends Marketing Services Engagement Alaska Energy Metals Corporation extends marketing agreement with Capital Gain Media Inc. for additional 2 months. $200,000 marketing budget allocated. Company focuses on sustainable critical material delivery for national security and energy future Sustainability National Security Marketing Agreement Critical Materials Alaska Energy Metals Corporation
PRESS RELEASE published on 04/29/2026 at 02:25, 2 months 9 days ago Organto Foods Announces Fiscal 2025 Financial Results Organto Foods Inc. reports strengthened balance sheet and record growth in audited fiscal 2025 results. CEO highlights positive financial platform and strong sales performance Financial Performance Organto Foods Inc. Balance Sheet Record Growth Fiscal 2025 Results
PRESS RELEASE published on 04/29/2026 at 01:30, 2 months 9 days ago First Helium Announces Private Placement First Helium Inc. announces non-brokered private placement financing of 40,000,000 Units at $0.05 per Unit, generating C$2 million for asset development and working capital Working Capital Private Placement Financing Units Asset Development First Helium Inc.
PRESS RELEASE published on 04/29/2026 at 00:20, 2 months 9 days ago Fountain Asset Corp. Announces Its Financial Results for the Quarter and Year Ended December 31, 2025 Fountain Asset Corp. announces financial results for Q4/25 and Fiscal 2025 showing NAV increase. Company maintains low operating expenses and strategic investments in technology and mining sectors Financial Results Investment Strategy NAV Increase Operating Expenses Fountain Asset Corp.
PRESS RELEASE published on 04/29/2026 at 00:00, 2 months 9 days ago LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules LIR Life Sciences Corp. announces the launch of a controlled ex vivo porcine skin study to evaluate protamine's impact on transdermal movement of macromolecular therapeutics. The study aims to advance needle-free delivery options for larger molecules Transdermal Delivery Lir Life Sciences Corp. Needle-free Delivery Protamine Macromolecular Therapeutics
Published on 07/08/2026 at 03:25, 33 minutes ago Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp
Published on 07/08/2026 at 01:10, 2 hours 48 minutes ago Galantas Announces Resignation of Chair of the Board
Published on 07/07/2026 at 23:15, 4 hours 43 minutes ago Guanajuato Silver Announces Officer Resignation
Published on 07/07/2026 at 22:15, 5 hours 43 minutes ago Grande Portage Closes C$6 Million Equity Financing
Published on 07/07/2026 at 21:25, 6 hours 33 minutes ago Pentagon I Capital Corp. and Prospectiva Resources LTD. Enter Into Definitive Agreement to Complete Qualifying Transaction and Announce Closing of Financing
Published on 07/08/2026 at 02:05, 1 hour 53 minutes ago 51Talk Marks 15th Anniversary with Global Curriculum Upgrade to Enhance Children's English Communication Skills
Published on 07/08/2026 at 01:05, 2 hours 53 minutes ago Stuck on the Sidelines: Carlsberg reveals Three-Quarters of Adults Will Watch Football This Summer, but a Third Haven't Played a Game in Six Months or More
Published on 07/07/2026 at 22:35, 5 hours 23 minutes ago DEFI TECHNOLOGIES INC. ANNOUNCES 2026 AGM VOTING RESULTS
Published on 07/07/2026 at 18:55, 9 hours 3 minutes ago Voyageurs du Monde: Proposed public tender offer for the securities of Voyageurs du Monde
Published on 07/07/2026 at 18:10, 9 hours 47 minutes ago LNA Santé and Euryale join forces to expand hospitalisation at home services across healthcare regions
Published on 07/07/2026 at 18:05, 9 hours 53 minutes ago Covivio - Half-yearly report on the liquidity contract on 30 June 2026
Published on 07/07/2026 at 18:01, 9 hours 57 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 07/07/2026 at 18:00, 9 hours 58 minutes ago Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel